March 06, 2015 6:01 AM ET


Company Overview of Celexion, LLC

Company Overview

Celexion, LLC, a bioengineering company, develops platform technologies and products for partners in the pharmaceutical, industrial, agricultural, and life science research sectors. It provides antibody discovery, antibody scaffold creation, antibody reformatting, affinity maturation, antibody humanization, metabolic pathway, life science tools, and product development services. The company was founded in 2009 and is based in Cambridge, Massachusetts.

One Kendall Square

Building 1400W

Suite B14302

Cambridge, MA 02139

United States

Founded in 2009





Key Executives for Celexion, LLC

Chief Executive Officer and Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Gahaga Biosciences, Inc. United States
Nodality, Inc. United States
Harta Corporation United States
Siva Therapeutics Inc. United States
Agilis Biotherapeutics, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Celexion, LLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at